Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.

NCT00775814 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Hypertension

Interventions

DRUG: Candesartan and Hydrochlorothiazide
DRUG: Hydrochlorothiazide (HCT)

Sponsor

Takeda